Literature DB >> 12764205

Is type A behavior really a trigger for coronary heart disease events?

John E J Gallacher1, Peter M Sweetnam, John W G Yarnell, Peter C Elwood, Stephen A Stansfeld.   

Abstract

OBJECTIVE: The purpose of this study was to compare chronic with acute mechanisms by which Type A might predict incident coronary heart disease (CHD).
METHOD: The study included 2394 men aged 50 to 64 years who were assessed for CHD, Type A behavior, and CHD risk factors. Type A was assessed using the Jenkins Activity Survey (JAS), the Bortner scale, and the Framingham scale. Further examinations were completed at 5 and 9 years for incident CHD.
RESULTS: After 9 years, there was no increased risk of CHD associated with any Type A score. Nevertheless, high Bortner scores were associated with increased risk of incident CHD at 5 years and high JAS and Bortner scores were associated with a decreased risk between 5 and 9 years. Further analysis of Type A scores on time to first coronary event found strong inverse associations for all type A scores (JAS = 205 -0.49 months to first event, 95% CI = -0.20, -0.78, p =.001) (Bortner = 176 -0.27 months; 95% CI = -0.10, -0.44; p =.002) (Framingham = 0.44 -0.0011 months; 95% CI = -0.0002, -0.0019; p =.01).
CONCLUSIONS: The data show Type A is a strong predictor of when incident coronary heart disease (or coronary event) will occur rather than if it will occur. These findings suggest that Type A increases exposure to potential triggers, rather than materially affecting the process of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12764205     DOI: 10.1097/01.psy.0000041608.55974.a8

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  7 in total

1.  Does personality explain social inequalities in mortality? The French GAZEL cohort study.

Authors:  Hermann Nabi; Mika Kivimäki; Michael G Marmot; Jane Ferrie; Marie Zins; Pierre Ducimetière; Silla M Consoli; Archana Singh-Manoux
Journal:  Int J Epidemiol       Date:  2008-02-14       Impact factor: 7.196

2.  Type A behavior pattern is not a predictor of premature mortality.

Authors:  Kastytis Šmigelskas; Nida Žemaitienė; Juhani Julkunen; Jussi Kauhanen
Journal:  Int J Behav Med       Date:  2015-04

3.  Life Psychosocial Stresses and Coronary Artery Disease.

Authors:  Babak Bagheri; Fatemeh Meshkini; Kolsoum Dinarvand; Zahra Alikhani; Mal Haysom; Mehdi Rasouli
Journal:  Int J Prev Med       Date:  2016-09-14

4.  A Type A and Type D Combined Personality Typology in Essential Hypertension and Acute Coronary Syndrome Patients: Associations with Demographic, Psychological, Clinical, and Lifestyle Indicators.

Authors:  Patrizia Steca; Marco D'Addario; Maria Elena Magrin; Massimo Miglioretti; Dario Monzani; Luca Pancani; Marcello Sarini; Marta Scrignaro; Luca Vecchio; Francesco Fattirolli; Cristina Giannattasio; Francesca Cesana; Salvatore Pio Riccobono; Andrea Greco
Journal:  PLoS One       Date:  2016-09-02       Impact factor: 3.240

5.  Impulsivity assessed ten years earlier and sociodemographic factors predict adherence to COVID-19 related behavioral restrictions in old individuals with hypertension.

Authors:  Patrizia Steca; Roberta Adorni; Andrea Greco; Francesco Zanatta; Francesco Fattirolli; Cristina Franzelli; Cristina Giannattasio; Marco D'Addario
Journal:  BMC Public Health       Date:  2022-01-27       Impact factor: 4.135

6.  Study of type a and B behavior patterns in patients with multiple sclerosis in an Iranian population.

Authors:  Vahid Shaygannejad; Sedigheh Rezaei Dehnavi; Fereshteh Ashtari; Somayeh Karimi; Leila Dehghani; Rokhsareh Meamar; Zahra Tolou-Ghamari
Journal:  Int J Prev Med       Date:  2013-05

7.  Factor structure and validity of Type D personality scale among Indian (Tamil-speaking) patients with acute myocardial infarction.

Authors:  Vikas Menon; Anoop G Pillai; Santhosh Satheesh; Charanya Kaliamoorthy; Siddharth Sarkar
Journal:  Indian J Psychiatry       Date:  2019 Nov-Dec       Impact factor: 1.759

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.